A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 3135-3142

  Liao, Fangxin ^a,b   He, Wenzhuo ^a,b   Jiang, Chang ^a,b   Yin, Chenxi ^a,b   Guo, Guifang ^a,b   Chen, Xuxian ^a,b   Qiu, Huijuan ^a,b   Rong, Yuming ^a,b   Zhang, Bei ^a,b   Xu, Dazhi ^a   Xia, Liangping ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b VIP Region ^*  (China)

Author keywords

High low density lipoprotein cholesterol; High density lipoprotein cholesterol; Metastatic colorectal cancer

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID ANALYSIS; LOW DENSITY LIPOPROTEIN CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN CHOLESTEROL RATIO; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

EID: 84945903874     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S90479     Document Type: Article

References (21)

1. Hu T, Yao Y, Yu S, et al. Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer. J Biomed Res. 2013;27(4):283-290.
2. Rose G, Blackburn H, Keys A, et al. Colon cancer and blood-cholesterol. Lancet. 1974;1(7850):181-183.
3. Vitols S, Gahrton G, Bjorkholm M, Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet. 1985;2(8465):1150-1154.
4. Saito N, Sairenchi T, Irie F, et al. Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: the Ibaraki Prefectural health study. Tohoku J Exp Med. 2013;229(3):203-211.
5. Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida JC. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer. 2014;14:132.
6. Notarnicola M, Altomare DF, Correale M, et al. Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology. 2005;68(4-6):371-374.
7. Liu YL, Qian HX, Qin L, Zhou XJ, Zhang B. Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer. Hepatogastroenterology. 2011;58(106):383-387.
8. Muntoni S, Atzori L, Mereu R, et al. Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis. 2009;19(3):218-225.
9. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327(5961):46-50.
10. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation. 1992;86(3):1046-1060.
11. Emberson JR, Kearney PM, Blackwell L, et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175, 000 people in 27 randomised trials of statin therapy. PLoS One. 2012;7(1):e29849.
12. Mack JT, Townsend DM, Beljanski V, Tew KD. The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds. Curr Drug Metab. 2007;8(1):47-57.
13. Laisupasin P, Thompat W, Sukarayodhin S, Sornprom A, Sudjaroen Y. Comparison of serum lipid profiles between normal controls and breast cancer patients. J Lab Physicians. 2013;5(1):38-41.
14. Montel V, Gaultier A, Lester RD, Campana WM, Gonias SL. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res. 2007;67(20):9817-9824.
15. Song H, Li Y, Lee J, Schwartz AL, Bu G. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res. 2009;69(3):879-886.
16. Li AJ, Elmore RG, Chen IY, Karlan BY. Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers. Gynecol Oncol. 2010;116(1):78-81.
17. Kuoppala J, Lamminpaa A, Pukkala E. Statins and cancer: a systematic review and meta-analysis. Eur J Cancer. 2008;44(15):2122-2132.
18. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a meta-analysis. JAMA. 2006;295(1):74-80.
19. Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol. 2006;24(30):4808-4817.
20. Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med. 2005;352(21):2184-2192.
21. Broughton T, Sington J, Beales IL. Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study. BMC Gastroenterol. 2012;12:36.